Cost-effectiveness of gene therapy for sickle cell disease in Uganda: tailoring high-income evidence to Uganda's context.
- DOI
- 10.1038/s41434-026-00598-1
- Published
- 2026 Mar
- Container
- Gene therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41434-026-00598-1,
title = {Cost-effectiveness of gene therapy for sickle cell disease in Uganda: tailoring high-income evidence to Uganda's context.},
author = {Montano-Campos JF and Adair JE and Basu A and Kyeyune RB and Bayigga L and Kityo-Mutuluuza C and Hansen R},
year = {2026},
journal = {Gene therapy},
doi = {10.1038/s41434-026-00598-1},
url = {https://doi.org/10.1038/s41434-026-00598-1}
}RIS
TY - JOUR TI - Cost-effectiveness of gene therapy for sickle cell disease in Uganda: tailoring high-income evidence to Uganda's context. AU - Montano-Campos JF AU - Adair JE AU - Basu A AU - Kyeyune RB AU - Bayigga L AU - Kityo-Mutuluuza C AU - Hansen R PY - 2026 JO - Gene therapy DO - 10.1038/s41434-026-00598-1 UR - https://doi.org/10.1038/s41434-026-00598-1 ER -
APA
JF, M., JE, A., A, B., RB, K., L, B., C, K., & R, H. (2026). Cost-effectiveness of gene therapy for sickle cell disease in Uganda: tailoring high-income evidence to Uganda's context.. Gene therapy. https://doi.org/10.1038/s41434-026-00598-1
Source records
- pubmed · retrieved 2026-09-26T18:22:24.607Z